Healthcare Services

Nuclear Medicine Market Anticipated to Record Steady Gains, Advancing to $17.13 Billion by 2030

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nuclear medicine market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Nuclear Medicine Market between 2026 and 2030?

The size of the nuclear medicine market has expanded quickly in recent years. It is projected to grow from $10.18 billion in 2025 to $11.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has been ascribed to factors including restricted access to nuclear imaging equipment, the high expense of radiopharmaceuticals, a scarcity of trained personnel, underdeveloped hospital and diagnostic center infrastructure, and insufficient patient awareness.

The nuclear medicine market is anticipated to experience substantial expansion over the next few years. It is projected to reach $17.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This growth during the forecast period is propelled by several factors, including a surging demand for advanced diagnostic and therapeutic methods, expanding government initiatives in cancer and cardiac care, increased uptake by hospitals and diagnostic centers, technological innovations in radiopharmaceuticals and imaging, and rising patient awareness alongside increased healthcare expenditure. Prominent trends expected in this timeframe encompass the wider adoption of diagnostic imaging techniques, increased utilization of therapeutic radiopharmaceuticals, a growing need for PET and SPECT scans, a heightened focus on oncology and cardiology applications, and broader implementation across hospitals and diagnostic facilities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Nuclear Medicine Market?

The rising constancy and prevalence of cardiovascular disease (CVD) and cancer are projected to drive the future growth of the nuclear medicine market. CVDs are disorders affecting the heart and blood vessels, while cancer is characterized by cells multiplying uncontrollably and spreading to other body parts. Nuclear cardiac imaging provides a quicker way to diagnose cardiac diseases. Furthermore, nuclear medicine therapy offers a treatment option for cancer, potentially utilized alongside or after other therapies such as surgery and chemotherapy. Consequently, the increasing constancy and prevalence of cardiovascular disease and cancer are boosting the demand for the nuclear medicine market. For instance, in January 2023, the American Cancer Society Inc., a US-based non-profit health group, anticipated 1,958,310 new cancer cases to be diagnosed in the US, which marks an increase compared to more than 1,918,030 new cancer cases in 2022. Hence, the escalating constancy and prevalence of cardiovascular diseases and cancer are actively propelling the nuclear medicine market.

What Segments Are Included Within The Nuclear Medicine Market?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

Which Trends Are Expected To Influence The Nuclear Medicine Market In The Upcoming Years?

Major companies operating in the nuclear medicine market are focusing on developing innovative solutions, including nuclear medicine cyclotrons, to enhance the production of radiopharmaceuticals and refine diagnostic imaging capabilities. Nuclear medicine cyclotrons are specialized particle accelerators that produce radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals utilized in procedures like positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, initiated the launch of its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are crucial for nuclear medicine, allowing for the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, strengthening capabilities in early disease detection and personalized treatment.

Who Are The Prominent Global Companies Shaping The Nuclear Medicine Market Landscape?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which Region Is Projected To Lead The Nuclear Medicine Market During The Forecast Period?

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nuclear Medicine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company

Medical Irradiation Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Nuclear Medicine Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Nuclear Medicine Radioisotopes Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-radioisotopes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795